Skip to main content
An official website of the United States government
Email

News & Events

2024 Technology Showcase

2024 Technology Showcase

Annual event highlighting how potential industry partners can work with the NCI and Frederick National Laboratory
Dr. James Gulley, Co-Director for Immuno-Oncology, Clinical Director, NCI

Video: New Treatment for Merkel Cell Carcinoma

TTC supported the path from discovery and collaborative development of a new type of treatment for Merkel cell carcinoma.

Recent News

Upcoming Events

  • Tech Webinar: Pigment Epithelium-Derived Factor Peptides for Treating Retinal Degeneration

    This webinar was originally scheduled for January 31, and rescheduled for May 22; it will now be rescheduled for fall 2024.
    Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 in the U.S. and 1.5 million people worldwide suffer from RP, which leads to progressive photoreceptor cell degeneration and ultimately vision loss. A new therapeutic technology from the National Eye Institute has the potential to be a treatment option for RP patients and may also protect retinal cells from damage associated with glaucoma and age-related macular degeneration (AMD). Attend the webinar to assess the technology for partnership and licensing opportunities.

    May 22, 2024 | 11:00 AM – 12:00 PM

  • 2024 Technology Showcase

    An annual event for potential industry partners and stakeholders highlighting cancer technologies and how to work with the NCI and the Frederick National Laboratory.

    September 4, 2024 | 9:00 AM – 4:30 PM
    Frederick, MD
Email